Cardiometabolic risk screening trends across U.S. primary care

Executive summary

Across a sample of U.S. outpatient primary care practices, lipid panel ordering and blood pressure re-checks for adults aged 40–64 increased modestly this quarter compared with the same period last year. The shift appears concentrated in practices that adopted structured pre-visit screening checklists. Clinical significance varies by practice size, and the trend should be read as directional rather than definitive.

Clinical findings

• Lipid panel orders rose in practices using automated pre-visit reminders, compared with practices relying on manual scheduling review.
• Blood pressure re-check intervals shortened slightly among patients with a prior elevated reading on file.
• Screening frequency showed regional variation, with the Northeast and West Coast samples reporting the most consistent follow-through.
• No meaningful change was observed in screening rates for patients without an established primary care relationship.

Biomarker trends

Commonly cited reference ranges for the markers discussed in this report, shown for general context. These are population-level reference points, not individual diagnostic thresholds.

Reference ranges reflect general population guidance and may differ by laboratory or individual clinical context.

Diagnostic interpretation

Increased screening volume does not, by itself, indicate a rise in cardiometabolic disease — it more likely reflects improved adherence to existing screening guidance. Editorial reviewers note that practices with structured checklists are identifying at-risk patients earlier in the visit rather than diagnosing more disease overall. Clinicians should interpret local screening-rate changes alongside their own patient population, not as a standalone diagnostic signal.

Supporting evidence

This report draws on de-identified, aggregate screening-order data voluntarily shared by participating outpatient practices, cross-referenced against publicly available guidance on cardiometabolic risk screening intervals. Sample size and regional mix are noted in the methodology appendix available on request.

References

1. American Heart Association — cardiovascular risk screening recommendations for adults.
2. U.S. Preventive Services Task Force — lipid disorder screening guidance.
3. CDC National Center for Health Statistics — ambulatory care visit data summaries.
4. ClinixDaily Editorial Board — quarterly practice-reported screening survey.